ROCKWELL MEDICAL, INC.
For the period ended Nov 12, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 12, 2025 · Filed Nov 12, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · OPERATING HIGHLIGHTS
OPERATING HIGHLIGHTS
During the third quarter of 2025, Rockwell Medical signed several new long-term product purchasing agreements with university medical centers, kidney centers and hospital systems. One agreement, with a single dialysis center located in southern Florida, included a three-year commitment, with the option to renew for two additional one-year periods, which has the potential to generate approximately $1 million in annualized net sales for the Company. At September 30, 2025, more than 80% of Rockwell Medical's customers remain under long-term contracts.
During the third quarter of 2025, the Company expanded its product purchase agreement with the largest provider of dialysis in skilled nursing facilities in the United States. The agreement will be in effect for three (3) years, with the option to renew for one (1) additional year, and includes supply and purchasing minimums for the Company's liquid and dry acid and bicarbonate concentrates including its bicarbonate cartridge, which officially launched earlier this year.
Rockwell Medical promoted Heather Hunter to Chief Operating Officer. Ms. Hunter joined Rockwell Medical in August 2022 as Chief Corporate Affairs Officer to revitalize the Company's investor relations, corporate communications, brand reputation, and market credibility. Subsequently, Ms. Hunter assumed responsibility for other functional areas including information technology and transportation.
Rockwell Medical was named by Great Place to Work a 2025 Fortune Best Workplaces in Manufacturing and Production TM in the small & medium category for the second year in a row.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.